Overview

Aspirin and Plavix Following Coronary Artery Bypass Grafting

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The design of the study will be randomized, double blind trial, which will examine the effects of addition of clopidogrel to current guideline recommended background therapy on lowering the incidence of graft stenosis after coronary artery bypass grafting compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Ahmad Slim
Collaborator:
Bristol-Myers Squibb
Treatments:
Aspirin
Clopidogrel
Ticlopidine